Nanocarrier-Based Targeting of Cluster of Differentiation 44 for Treating Atherosclerosis: A Review Article

Wang, Duo, Zhang, Wenbin, Xu, Dexin et al. (2023). Nanocarrier-Based Targeting of Cluster of Differentiation 44 for Treating Atherosclerosis: A Review . Journal of Biomedical Nanotechnology, 19(3), 349-363. 10.1166/jbn.2023.3526

cited authors

  • Wang, Duo; Zhang, Wenbin; Xu, Dexin; Wang, Wenhai; Liu, Ying; Ding, Jian

sustainable development goals

authors

publication date

  • March 1, 2023

published in

keywords

  • ACCUMULATION
  • ATHEROGENESIS
  • Atherosclerosis
  • CD44 RECEPTOR
  • CD44 Targeting
  • CELLS
  • DRUG-DELIVERY
  • HA Nanoparticles
  • HYALURONIC-ACID
  • INFLAMMATION
  • IRON-OXIDE NANOPARTICLES
  • Materials Science
  • Materials Science, Biomaterials
  • Nanocarriers
  • Nanoscience & Nanotechnology
  • PLAQUE STABILITY
  • PROTEOGLYCANS
  • Science & Technology
  • Science & Technology - Other Topics
  • Technology
  • Therapeutic Ligand

Digital Object Identifier (DOI)

publisher

  • AMER SCIENTIFIC PUBLISHERS

start page

  • 349

end page

  • 363

volume

  • 19

issue

  • 3